Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma.
Hsu CM, Kao SY, Yen CH, Hsiao CE, Cho SF, Wang HC, Yeh TJ, Du JS, Wang MH, Hsieh TY, Hsiao SY, Tsai Y, Hung LC, Liu YC, Chang KC, Hsiao HH.
Hsu CM, et al.
Oncol Lett. 2024 Oct 25;29(1):30. doi: 10.3892/ol.2024.14776. eCollection 2025 Jan.
Oncol Lett. 2024.
PMID: 39512504
Free PMC article.